Literature DB >> 29167891

The Promise and Challenges of CAR-T Gene Therapy.

Bridget M Kuehn.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 29167891     DOI: 10.1001/jama.2017.15605

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

Review 1.  Programming Cell-Cell Interactions through Non-genetic Membrane Engineering.

Authors:  Clifford M Csizmar; Jacob R Petersburg; Carston R Wagner
Journal:  Cell Chem Biol       Date:  2018-06-14       Impact factor: 8.116

Review 2.  Oxidative Stress in Cancer Immunotherapy: Molecular Mechanisms and Potential Applications.

Authors:  Ruolan Liu; Liyuan Peng; Li Zhou; Zhao Huang; Chengwei Zhou; Canhua Huang
Journal:  Antioxidants (Basel)       Date:  2022-04-27

3.  Postinfusion monitoring costs by site of care for patients with relapsed/refractory large B-cell lymphoma receiving third- or later-line treatment with lisocabtagene maraleucel in the TRANSCEND NHL 001 and OUTREACH trials.

Authors:  M Lia Palomba; Monika Parisi Jun; James Lymp; Andy Nguyen; November McGarvey; Matthew Gitlin; Corey Pelletier; Scott J Keating; John Godwin
Journal:  Leuk Lymphoma       Date:  2021-05-21

4.  Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma.

Authors:  Gary H Lyman; Andy Nguyen; Sophie Snyder; Matthew Gitlin; Karen C Chung
Journal:  JAMA Netw Open       Date:  2020-04-01

Review 5.  The Applications of Metabolic Glycoengineering.

Authors:  Liwei Ying; Junxi Xu; Dawei Han; Qingguo Zhang; Zhenghua Hong
Journal:  Front Cell Dev Biol       Date:  2022-02-17

6.  The importance of cell culture parameter standardization: an assessment of the robustness of the 2102Ep reference cell line.

Authors:  James Willard Tonderai Kusena; Maryam Shariatzadeh; Adam James Studd; Jenna Rebekah James; Robert James Thomas; Samantha Loiuse Wilson
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.